Life Sciences companies used to wait until commercialization to build out Sales and Marketing leadership. Not anymore. Today, CEOs and Investors are hiring commercial leaders earlier — often pre-revenue — to shape the strategy and drive valuation. Here’s why that shift is accelerating.
Read more
